How Many Years of Aromatase Inhibitor Tx in Breast Cancer? How Many Years of Aromatase Inhibitor Tx in Breast Cancer?

There was no disease-free or overall survival benefit with 5 additional years of aromatase inhibitor therapy vs 2 years for women with hormone receptor –positive breast cancers.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news